How do anticoagulants impact thromboinflammatory responses in COVID-19 patients, and what are the implications for managing coagulopathy in severe cases?
Gaurav ChauhanContributor
How do anticoagulants affect thromboinflammatory responses in COVID-19 patients?
Share
Anticoagulants reduce clot formation and inflammation in COVID-19, potentially lowering complications like stroke and organ damage in severe cases.
Anticoagulants, used in severe COVID-19, help manage coagulopathy by limiting thrombosis and inflammation, crucial for preventing organ failures.